Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich and Carson Kessler

in

Clinical Trials, Drugs (Pharmaceuticals), Eisai Co Ltd, Elderly, Eli Lilly and Company, Food and Drug Administration, Genetics and Heredity, Government Accountability Office, Hemorrhagic Stroke, Institute for Clinical and Economic Review, Kisunla, Leqembi (Drug), Medicine and Health, Novartis AG, Retirement Communities and Assisted Living, United States, Villages, The (Fla)
←Joe Biden Goes Dark Brandon To Put Donald Trump’s ‘Concept Of A Plan’ On Blast
4 Can’t-Miss Towns in an Often Overlooked Corner of Japan→

More posts

  • Who are the real winners of Celebrity Traitors?

  • Are Manchester United really at risk of a relegation scrap?

  • Chili’s Margaritas Rimmed With Degreaser Burn 5 People in North Carolina

  • Taika Waititi Calls ‘Klara and the Sun’ Critics “Irrelevant, Out Of Touch, Obsolete”

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube